Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,761 | -9,107 | -39,696 | -32,575 | -26,141 |
| Depreciation Amortization | 1,726 | 888 | 4,577 | 3,568 | 2,483 |
| Accounts receivable | -5,539 | -75 | 2,812 | 1,953 | 173 |
| Other Working Capital | -5,166 | -2,013 | -5,892 | -1,888 | -2,722 |
| Other Operating Activity | 12,712 | -1,437 | -5,284 | -549 | 3,507 |
| Operating Cash Flow | $-22,028 | $-11,744 | $-43,483 | $-29,491 | $-22,700 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,493 | 2,429 | -25,568 | -159 | -1,707 |
| PPE Investments | -71 | -218 | 1,604 | 1,485 | 1,384 |
| Investing Cash Flow | $7,422 | $2,211 | $-23,964 | $1,326 | $-323 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,623 | N/A | 46,960 | 4,189 | N/A |
| Other Financing Activity | -9 | -4 | -3,787 | -3,782 | -3,782 |
| Financing Cash Flow | $6,614 | $-4 | $43,173 | $407 | $-3,782 |
| Beginning Cash Position | 14,555 | 14,555 | 38,829 | 38,829 | 38,829 |
| End Cash Position | 6,563 | 5,018 | 14,555 | 11,071 | 12,024 |
| Net Cash Flow | $-7,992 | $-9,537 | $-24,274 | $-27,758 | $-26,805 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,028 | -11,744 | -43,483 | -29,491 | -22,700 |
| Capital Expenditure | -250 | -218 | -130 | -105 | -103 |
| Free Cash Flow | -22,278 | -11,962 | -43,613 | -29,596 | -22,803 |